The trend toward digital mammograms was given a mixed report card in the study Benefits, Harms, and Costs for Breast Cancer Screening After U.S. Implementation of Digital Mammography e-published on May 28 in the Journal of the National Cancer Institute.
Each year at the Birnbaum Lecture, Group Health Research Institute presents the Birnbaum Award to Group Health staff who’ve made extraordinary contributions to the organization’s development as a learning health care system. At the 2014 Lecture, the award will be presented to people involved in three outstanding projects, all funded by Group Health’s Partnership for Innovation.
Diana Buist, PhD, MPH, is joining AcademyHealth as a Senior Scholar in Residence starting this month. In this position, she will apply her expertise in delivery system and multi-site projects to efforts to improve research translation and the speed with which evidence is effectively applied in health policy.
Group Health Research Institute’s Center for Community Health and Evaluation conducted a three-year evaluation to assess the impact of health impact assessments in the United States and to identify elements critical for success.
Group Health Research Institute Scientific Highlights—April 2014
For the three million women in the United States who’ve survived breast cancer, difficult health care choices come with the territory. But even after successful treatment, an important question lingers: Should they consider magnetic resonance imaging (MRI) in addition to mammography for ongoing breast cancer screening, or “surveillance”?
As a health services researcher, I know the toll society pays when we fail to help patients talk about and plan for eventualities like end-of-life care. Surveys show most Americans would prefer to die peacefully at home—and a recent study shows increasingly more are doing so. But the same study also reports that in their last three months, more patients are being hospitalized—and more often in intensive care units.
